CSL makes vaccines and has technological know how on influenza. Coronavirus is different and what CSL offers is adjacencies in expertise, facility and likely role of its adjuvant technology (read donation of adjuvant technology for development of COVID-19 vaccine). CSL is not doing this to make money but to contribute to a bigger cause.
As far as the outcome goes, I am hoping that the report will be made available to the scientific community by UQ rather than CSL.
I remain clueless about what Biotron has to do on this thread.
CSL makes vaccines and has technological know how on influenza....
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.90 |
Change
-0.020(0.01%) |
Mkt cap ! $148.7B | |||
| Open | High | Low | Value | Volume |
| $307.40 | $307.90 | $304.87 | $201.6M | 655.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 863 | $307.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.92 | 211 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |